Dominic Smethurst

Dominic Smethurst

Corporate Officer/Principal at
Faculty of Pharmaceutical Medicine

Net worth: 174 833 $ as of 31/08/2026

52 year
Health Technology
Consumer Services
Commercial Services

Profile

Dominic Smethurst is currently a Member at The Royal College of Physicians and a Member at the Faculty of Pharmaceutical Medicine.
Former roles include Chief Medical Officer at Bicycle Therapeutics Plc from 2020 to 2023, Chief Medical Officer at Nordic Nanovector ASA in 2020, Chief Medical Officer at Tusk Therapeutics Ltd. from 2016 to 2018, Vice President-Oncology & Global Therapeutic Area at ICON plc from 2015 to 2016, Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc. from 2024 to 2026, Chief Medical Officer at Oncoinvent ASA, and Venture Partner at SV Health Investors LLP.
Education includes undergraduate studies at the University of Cambridge and graduate studies at Christ's College (United Kingdom).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/03/2026 16,025 ( 0.08% ) 174 833 $ 31/08/2026

Dominic Smethurst active positions

CompaniesPositionStart
Faculty of Pharmaceutical Medicine
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Dominic Smethurst

CompaniesPositionEnd
CORBUS PHARMACEUTICALS HOLDINGS, INC. Chief Tech/Sci/R&D Officer 30/06/2026
BICYCLE THERAPEUTICS PLC Chief Tech/Sci/R&D Officer 31/03/2023
THOR MEDICAL Chief Tech/Sci/R&D Officer 10/08/2020
Chief Tech/Sci/R&D Officer 01/09/2018
ICON PUBLIC LIMITED COMPANY Corporate Officer/Principal 01/09/2016
See the detail of Dominic Smethurst's experience

Training of Dominic Smethurst

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Commercial Services

Finance

Consumer Services

Consumer Services

Faculty of Pharmaceutical Medicine

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Dominic Smethurst